Purpose

This is a randomized control trial testing the effect of walnut supplementation on prostate cancer progression in 50 men with biopsy confirmed prostate cancer and planning to undergo RP. Patients consented to the study will be randomly assigned to either continue their usual diets (control arm) or to the walnut arm for 4-10 weeks depending on the window between their consent date and the date for RP.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Pathologically confirmed prostate adenocarcinoma. - Diagnostic biopsy cores with ≥10 cores with each core examined separately to determine exact tumor location. - Biopsy grade group 2 or higher (Gleason ≥7). - Planning to undergo RP. - Willing to adhere to a usual diet with the possible addition of 2 oz of walnuts per day. - Reads, writes, and understands English. - Age 18 or older

Exclusion Criteria

  • Allergy to nuts. - History of receiving hormone therapy or antiandrogen therapy. - Use of 5-alpha reductase inhibitors in the past 6 months. - Prior prostate radiotherapy (external beam or brachytherapy) or prior prostate cryotherapy. - Currently enrolled in a modified diet/weight loss program and/or taking dietary supplements that contain omega-3s (e.g., fish oil). - Other active malignancy, excluding basal cell carcinoma or squamous cell carcinoma - Significant co-morbidities (e.g., cardiac, pulmonary, liver disease, alcohol/drug addiction, malabsorption syndromes), that in the opinion of the study physician make the patient ineligible. - Individuals with psychological/mental conditions which can affect the consent process and/or their adherence to the protocol.

Study Design

Phase
Phase 2
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Usual Diet + Walnuts
Usual diet with the addition of two ounces of walnuts daily, phone counseling with dietitian, for 4-10 weeks
  • Other: walnuts
    2 ounces of walnuts daily for 4-10 weeks
  • Other: usual diet
    Subject continues usual diet
  • Other: phone counseling with dietitian
    Weekly calls with dietitian
Active Comparator
Usual Diet
Usual diet for 4-10 weeks
  • Other: walnuts
    2 ounces of walnuts daily for 4-10 weeks
  • Other: usual diet
    Subject continues usual diet
  • Other: phone counseling with dietitian
    Weekly calls with dietitian

Recruiting Locations

Cedars-Sinai Medical Center
Los Angeles 5368361, California 5332921 90048
Contact:
Kara Bissell
424-314-0743
kara.bissell@cshs.org

Durham VA Medical Center
Durham 4464368, North Carolina 4482348 27705
Contact:
Haleigh E Bellerose
919-286-0411
Haleigh.Bellerose@va.gov

More Details

NCT ID
NCT03824652
Status
Recruiting
Sponsor
Stephen Freedland

Study Contact

Yunhee Choi-Kuaea, MSW
310-423-0333
Yunhee.Choi-Kuaea@cshs.org

Detailed Description

The overall objective of this study is to test the effect of walnuts added to a usual diet on prostate cancer progression as measured by Ki67 expression in the prostate tissues. Subjects will be randomized 1:1 to usual diet or usual diet with the addition of 2 ounces of walnuts daily. The baseline visit will occur in conjunction with a standard of care visit post-biopsy, the intervention period will range from 4-10 weeks dependent upon the scheduled date of the standard of care radical prostatectomy (RP), and the final visit will occur in conjunction with a standard of care visit prior to RP.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.